Olanzapine for the Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting

Malignant tumours
doi 10.18027/2224-5057-2018-8-3-21-30
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Russian Society of Clinical Oncology

Related search

Corticosteroids in the Treatment of Chemotherapy-Induced Nausea and Vomiting

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2012English

Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting: Approval and Efficacy

Cancer Management and Research
Oncology
2009English

Treatment of Nausea and Vomiting During Chemotherapy

Oncology & Hematology Review (US)
2011English

Olanzapine Combined With Standard Antiemetic Regimens for Prevention of Chemotherapy Therapy-Induced Nausea and Vomiting: A Single-Center Experience From South India

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2017English

Dronabinol for Chemotherapy-Induced Nausea and Vomiting Unresponsive to Antiemetics

Cancer Management and Research
Oncology
2016English

Cannabinoids for Control of Chemotherapy Induced Nausea and Vomiting: Quantitative Systematic

BMJ
2001English

Rolapitant in the Treatment of Nausea and Vomiting Associated With Chemotherapy

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2017English

Stability of Azasetron-Dexamethasone Mixture for Chemotherapy-Induced Nausea and Vomiting Administration

Oncotarget
Oncology
2017English

Neurokinin-1 Receptor Antagonists: Review of Their Role for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Adults

Expert Review of Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy